TVT 2021 - Case Presentation: High-Risk Severe AR Treated with a Commercial TAVR Device
By JenaValve FEATURING Torsten Vahl, Tom Cahill, Michael Mack
January 25, 2022
This is a presentation from Dr. Cahill, followed by a panel discussion with Drs. Mack, Vahl, and Treede. Part of the TVT 2021 Structural Heart Summit.
Part 2/6. Click Here to Watch the next Part 3/6
Click here to Watch the Full Video
The Trilogy Heart Valve System is not for sale in the US and is limited by Federal (or United States) law to investigational use.
Login to view comments. Click here to Login